Skip to main content
SpringerLink
Log in

Antagonism of the analeptic activity of thyrotropin-releasing hormone (TRH) by agents which enhance GABA transmission

  • Animal Studies
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Administration of 10 mg/kg TRH to mice was found to reduce the sleep and hypothermia induced by 4.7 g/kg ethanol. However, TRH did not reduce the sleep of mice that were given γ-hydroxybutyric acid (GHBA), baclophen, or aminooxyacetic acid (AOAA) in combination with 3 g/kg ethanol. TRH also failed to reverse the hypothermia induced by the combination of ethanol and baclophen or GHBA, and the characteristic neurological effects of TRH e.g. tremor, increased muscle tone, and increased respiratory rate were reduced. In addition, TRH-induced locomotor stimulation was prevented by pretreatment with small doses of the GABA-ergic agents, and while 30 mg/kg TRH reduced the hypothermia produced by large doses of the GABA-ergic drugs, it did not antagonize the locomotor retardation produced by baclophen or GHBA. A hypothesis that the analeptic effects of TRH may be mediated via an inhibition of GABA systems is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aghajanian, G. K., Roth, R. H.: γ-Hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy. J. Pharmacol. exp. Ther. 175, 131–138 (1970)

    Google Scholar 

  • Andén, N. E., Stock, G.: Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 89–92 (1973)

    Google Scholar 

  • Andén, N. E., Wachtel, H.: Biochemical effects of baclofen (β-parachlorophenyl-GABA) on the dopamine and noradrenaline in the rat brain. Acta pharmacol. (Kbh.) 40, 310–320 (1977)

    Google Scholar 

  • Beleslin, D. B., Samardzic, R.: Failure of autonomic and central nervous system blocking agents to antagonize the groos behavioural effects of tubocurarine injected intraventricularly in conscious cats. J. Pharm. Pharmacol. 28, 519 (1976)

    Google Scholar 

  • Breese, G. R., Cooper, B. R., Prange, A. J., Cott, J. M., Lipton, M. A.: Interactions of thyrotropin-releasing hormone with centrally acting drugs. In: The thyroid axis, drugs and behavior, A. J. Prange, ed., pp. 115–127. New York: Raven Press 1974a

    Google Scholar 

  • Breese, G. R., Cott, J. M., Cooper, B. R., Prange, A. J., Lipton, M. A.: Antagonism of ethanol narcosis by thyrotropin-releasing hormone. Life Sci. 14, 1053–1063 (1974b)

    Google Scholar 

  • Breese, G. R., Cott, J. M., Cooper, B. R., Prange, A. J., Lipton, M. A., Plotnikoff, N. P.: Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs. J. Pharmacol. exp. Ther. 193, 11–22 (1975)

    Google Scholar 

  • Brown, M., Vale, W.: Central nervous system effects of hypothalamic peptides. Endocrinology 96, 1333–1336 (1975)

    Google Scholar 

  • Carlsson, A.: Pharmacological approach to schizophrenia. In: Schizophrenia: Biological and physiological perspectives, G. Usdin, ed., pp. 102–124. New York: Brunner/Mazel Pub. 1975

    Google Scholar 

  • Cohn, M. L.: Cyclic AMP, thyrotropin-releasing factor, and somatostatin: Key factors in the regulation of the duration of narcosis. In: Molecular mechanisms of anesthesia, progress in anesthesiology, Vol. 1, B. R. Fink, ed., pp. 485–500. New York: Raven Press 1975

    Google Scholar 

  • Collins, G. G. S.: GABA-2-oxoglutarate transaminase, glutamate decarboxylase and the half-life of GABA in different areas of rat brain. Biochem. Pharmacol. 21, 2849–2858 (1972)

    Google Scholar 

  • Cott, J. M., Breese, G. R., Cooper, B. R., Barlow, T. S., Prange, A. J., Jr.: Investigation into the mechanism of reduction of ethanol sleep by thyrotroping-releasing hormone (TRH). J. Pharmacol. exp. Ther. 196, 594–604 (1976a)

    Google Scholar 

  • Cott, J. M., Carlsson, A., Engel, J., Lindqvist, M.: Suppression of ethanol-induced locomotor stimulation by GABA-like drugs. Naunyn-Schmiedeberg's Arch. Pharmacol. 295, 203–209 (1976b)

    Google Scholar 

  • Curtis, D. R., Game, C. J. A., Johnston, G. A. R., McCulloch, R. M.: Central effects of β-(-p-chlorophenyl)-γ-aminobutyric acid. Brain Res. 70, 493–499 (1974)

    Google Scholar 

  • Davies, J., Watkins, J. C.: The action of β-phenyl-GABA derivatives on neurones of the cat cerebral cortex. Brain Res. 70, 501–505 (1974)

    Google Scholar 

  • Dray, A., Straughan, D. W.: Synaptic mechanisms in the substantia nigra. J. Pharm. Pharmacol. 28, 400–405 (1976)

    Google Scholar 

  • Fahn, S.: Regional distribution studies of GABA and other putative neurotransmitters and their enzymes. In: GABA in nervous system function, E. Roberts, T. N. Chase, and D. B. Tower, eds., pp. 169–186. New York: Raven Press 1976

    Google Scholar 

  • Fuxe, K., Agnati, L. F., Hökfelt, T., Jonsson, G., Lidbrink, P., Ljungdahl, Å.: The effect of dopamine receptor stimulating and blocking agents on the activity of supersensitive dopamine receptors and on the amine turnover in various dopamine nerve terminal systems in the rat brain. J. Pharmacol. 6, 117–129 (1975a)

    Google Scholar 

  • Fuxe, K., Hökfelt, T., Ljungdahl, Å., Agnati, L., Johansson, O., Perez de la Mora, M.: Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs. Med. Biol. 53, 177–183 (1975b)

    Google Scholar 

  • Haefely, W.: Paper presented at the 10th C.I.N.P. meeting, Quebec 1976

  • Hill, R. G., Simmonds, M. A., Straughan, D. E.: A comparative study of some convulsant substances as γ-aminobutyric acid antagonists in the feline cerebral cortex. Brit. J. Pharmacol. 49, 37–51 (1973)

    Google Scholar 

  • Hökfelt, T., Fuxe, K., Johansson, O., Jeffcoat, S., White, N.: Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Europ. J. Pharmacol. 34, 389–392 (1975)

    Google Scholar 

  • Horita, A., Carino, M. A.: Thyrotropin-releasing hormone (TRH)-induced hyperthermia and behavioral excitation in rabbits. Psychopharm. Commun. 1, 403–414 (1975)

    Google Scholar 

  • Hornykiewicz, O., Lloyd, K. G., Davidson, L.: The GABA system, function of the basal ganglia, and Parkinson's disease. In: GABA in nervous system function, E. Roberts, T. N. Chase, and O. B. Tower, eds., pp. 479–485. New York: Raven Press 1976

    Google Scholar 

  • Horst, W. D., Spirt, N.: A possible mechanism of the antidepressant activity of thyrotropin releasing hormone. Life Sci. 15, 1073–1082 (1974)

    Google Scholar 

  • Kääriäinen, I.: Effects of aminooxyacetic acid and baclofen on the catalepsy and the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats. Acta pharmacol. (Kbh.) 39, 393–400 (1976)

    Google Scholar 

  • McKenzie, G. M., Viik, K.: Chemically induced choreiform activity: antagonism by GABA and EEG patterns. Exp. Neurol. 46, 229–243 (1975)

    Google Scholar 

  • Melberg, P.-E., Ahlenius, S., Engel, J., Lundborg, P.: Ontogenic development of locomotor activity and rate of tyrosine hydroxylation. Psychopharmacology 49, 119–123 (1976)

    Google Scholar 

  • Plotnikoff, N. P., Prange, A. J., Jr., Breese, G. R., Anderson, M. S., Wilson, I. C.: Thyrotropin-releasing hormone: enhancement of DOPA activity by a hypothalamic hormone. Science 178, 417–418 (1972)

    Google Scholar 

  • Prange, A. J., Breese, G. R., Cott, J. M., Martin, B. R., Cooper, B. R., Wilson, I. C., Plotnikoff, N. P.: Thyrotropin-releasing hormone: antagonism of pentobarbital in rodents. Life Sci. 14, 447–455 (1974)

    Google Scholar 

  • Roberts, E.: A model of the vertebrate nervous system based largely on disinhibition: a key role of the GABA system. In: Neurohumoral coding of brain function, R. D. Myers, ed., pp. 419–449. New York: Plenum Press 1974

    Google Scholar 

  • Roth, R. H., Suhr, Y.: Mechanism of the γ-hydroxybutyrate-induced increase in brain dopamine and its relationship to “sleep”. Biochem. Pharmacol. 19, 3001–3012 (1970)

    Google Scholar 

  • Roth, R. H., Walters, J. R., Aghajanian, G. K.: Effects of impulse flow on the release and synthesis of dopamine in the rat striatum. In: Frontiers of catecholamine research, E. Usdin and S. Snyder, eds., pp. 567–574. New York: Pergamon 1973

    Google Scholar 

  • Stock, G., Magnusson, T., Andén, N.-E.: Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 347–361 (1973)

    Google Scholar 

  • Wallach, D. P.: Studies on the GABA pathway. I. The inhibition of γ-aminobutyric acid α-ketogluturic acid transaminase in vitro and in vivo by U-7524 (aminooxyacetic acid). Biochem. Pharmacol. 5, 323–331 (1961)

    Google Scholar 

  • Wood, J. D., Peesker, S. J.: The role of GABA metabolism in the convulsant and anticonvulsant actions of aminooxyacetic acid. J. Neurochem. 20, 379–386 (1973)

    Google Scholar 

Download references

Author information

Author notes

  1. Jerry Cott

    Present address: Department of Pharmacology, University of Ibadan, Ibadan, Nigeria

Authors and Affiliations

  1. Department of Pharmacology, University of Göteborg, S-400 33, Göteborg, Sweden

    Jerry Cott & Jörgen Engel

Authors
  1. Jerry Cott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jörgen Engel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cott, J., Engel, J. Antagonism of the analeptic activity of thyrotropin-releasing hormone (TRH) by agents which enhance GABA transmission. Psychopharmacology 52, 145–149 (1977). https://doi.org/10.1007/BF00439101

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00439101

Key words

Search

Navigation